Clontech Laboratories, Inc. Signs Agreement With For Access To Smart-Seq2

As a result of this agreement, Clontech will become the exclusive supplier of SMART-Seq2 technology. "We have a strong interest in advancing single-cell RNA-seq technology and applications, and we are deeply committed to continuing to develop products that will enable such advances by boosting assay sensitivity for studies essential to a wide variety of biological fields," commented , President of Clontech Laboratories, Inc. "Our focus continues to be on providing new solutions to customers, enabling them to work with the most challenging samples."

http://ift.tt/1CRC5sS